olivLaw · European equity research
MEDCAW INVESTMENTS PLC TAR.L
United Kingdom · London Stock Exchange · ISIN GB00BM8SQP62 · Vertical: Listed companies from United Kingdom
MEDCAW INVESTMENTS PLC is a British investing company that aims to identify and acquire early-stage natural resource assets. Its loss before taxation for fiscal 2025 was £144,478, and the company is in transition toward a gold project in Ontario, Canada, pending completion of the transaction and admission to AIM.
At the close of 05 Nov 2026, MEDCAW INVESTMENTS PLC (TAR.L) stock was 0.01 GBP (+0.00% on the day), with 52-week range 0.00–0.03 GBP.
Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 36.7
- weak (30–45)
- Bollinger (20, 2)
- 0.01 – 0.01
- in the lower half of the band · %B 0.29 · band width 21.2%
- SMA 50 / 200
- 0.01 / unavailable
- MACD (12, 26, 9)
- -0.00 / -0.00
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | −12.5% | −0.6% | −11.9 pp | — |
| 3 months | −5.8% | −4.2% | −1.6 pp | — |
| 6 months | unavailable | +4.3% | unavailable | — |
| Year to date | unavailable | +7.5% | unavailable | — |
| 1 year | −61.1% | +9.9% | −71.0 pp | +5.8% |
| 3 years | unavailable | +49.8% | unavailable | +26.3% |
| 5 years | unavailable | +42.8% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
EPS unavailable in the issuer's structured filings (e.g. a partnership reports per unit, not per share).
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Revenue YoY | unavailable | unavailable |
| Net income | -432.4 k | -144.5 k |
| Net income YoY | unavailable | unavailable |
| Diluted EPS | unavailable | unavailable |
| Diluted EPS YoY | unavailable | unavailable |
| net % | unavailable | unavailable |
| Free cash flow | unavailable | unavailable |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 320.8 k GBP
- Financial debt
- unavailable GBP
- Net debt
- unavailable GBP
- Equity
- -256.7 k GBP
- Total assets
- 365.2 k GBP
- Debt / equity
- unavailable
- Current ratio
- unavailable
- ROE
- unavailable
- ROA
- -62.3%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (GBP)
Income statement · GBP
Balance sheet · GBP
Cash flow · GBP
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 0 of at least 6
- score weight coverage: 0.0% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: unavailable
Key indicators
Coverage and freshness
Score by group
0% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 0 of at least 6; score weight coverage: 0.0% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | unavailable | unavailable | — |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | unavailable | unavailable | — |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partialunavailable · 0/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality· partialunavailable · 0/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
MEDCAW INVESTMENTS PLC (TAR.L). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 0 GBP in 2025.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 0 of at least 6; score weight coverage: 0.0% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
What contradicts it
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, Current ratio, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Listed companies from United Kingdom · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| BATS.LBritish American Tobacco P.L.C. | 104.3 bn | 13.5 | 16.5% | 30.3% | −1.0% | +7% / +88% |
| ABF.LAssociated British Foods PLC | 14.7 bn | 14.3 | 9.2% | 5.3% | −3.1% | −5% / −15% |
| 0EV1.LCarnival PLC | 5.5 bn | 4.1 | 46.7% | 13.4% | +6.4% | unavailable / unavailable |
| BAB.LBabcock International Group PLC | 5.1 bn | 24.7 | 34.7% | 4.1% | +7.2% | −10% / +158% |
| AUTO.LAutotrader Group PLC | 4.8 bn | 16.4 | 60.2% | 47.1% | +3.9% | −13% / −23% |
| BBY.LBalfour Beatty PLC | 4.2 bn | 16.3 | 23.2% | 2.8% | +15.2% | +20% / +160% |
| ABDN.LAberdeen Group PLC | 4.1 bn | 10.8 | 8.0% | 28.9% | −2.1% | +11% / +41% |
| BKG.LThe Berkeley Group Holdings PLC | 3.6 bn | 11.3 | 8.8% | 13.4% | −4.2% | −0% / −22% |
| BME.LB&M European Value Retail PLC | 2.9 bn | 17.4 | 21.2% | 2.8% | +3.7% | +68% / −51% |
| AJB.LAj Bell PLC | 2.4 bn | 22.8 | 49.9% | 33.1% | +18.0% | +8% / +128% |
| ASHM.LAshmore Group PLC | 1.4 bn | 13.9 | 13.1% | 71.6% | −0.1% | +28% / +18% |
| BCG.LBaltic Classifieds Group PLC | 1.2 bn | 23.2 | 15.8% | 57.6% | +6.9% | −99% / −99% |
| APN.LApplied Nutrition PLC | 763.6 m | 36.2 | 41.2% | 19.7% | +24.2% | +71% / unavailable |
| BAG.LA.G. Barr P.L.C. | 671.9 m | 14.4 | 14.4% | 10.8% | +4.0% | −7% / +26% |
| ASC.LAsos PLC | 494.5 m | — | -81.3% | -12.0% | −14.7% | +71% / +8% |
| ALFA.LAlfa Financial Software Holdings PLC | 486.8 m | 16.3 | 61.5% | 23.8% | +15.3% | −28% / +10% |
| AML.LAston Martin Lagonda Global Holdings PLC | 344.3 m | — | -93.4% | -39.2% | −20.6% | −45% / −85% |
| APTD.LAptitude Software Group PLC | 111.3 m | 28.5 | 7.2% | 6.2% | −7.3% | −30% / −23% |
| AMGO.LAmigo Holdings PLC | 9.9 m | — | — | — | −81.9% | +325% / +844% |
| ASBE.LAssociated British Engineering PLC | 605.3 k | — | -19.1% | — | unavailable | unavailable / unavailable |
| AMIF.LAmicorp Fs (uk) PLC | 221.6 k | 0.1 | 27.5% | 9.1% | +8.1% | unavailable / unavailable |
| AAF.LAirtel Africa PLC | — | — | 24.1% | 10.6% | +29.5% | −7% / +164% |
| AAL.LAnglo American PLC | — | — | -19.3% | -20.2% | +4.5% | +30% / +76% |
| ACG.LAcg Metals Limited | — | — | -80.3% | -32.0% | +134.8% | +60% / +63% |
| AEP.LAnglo-Eastern Plantations PLC | — | — | 16.1% | 19.5% | +25.0% | +5% / +113% |
1- and 3-year price returns: for TAR.L from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
MEDCAW INVESTMENTS PLC is a British investing company that aims to identify and acquire early-stage natural resource assets. Its loss before taxation for fiscal 2025 was £144,478, and the company is in transition toward a gold project in Ontario, Canada, pending completion of the transaction and admission to AIM 1.
SWOT
Strengths
- The company has a formal governance framework with internal financial controls and an anti-corruption policy, and the board focuses on compliance with listing rules 1.
- The focus on gold in Ontario is described as clear and tied to a specific project, giving shareholders a defined direction 1.
- The board showed discipline in abandoning the Abyssinian Metals reverse takeover when risks increased, which indicates a cautious approach 1.
Weaknesses
- The company has no revenue-generating operations and depends on capital raised to cover its current costs 1.
- The board is small and no audit or remuneration committees are yet constituted; they are to be set up after an acquisition 1.
- The strategy rests on a recent change of direction from life sciences to natural resources, which may create uncertainty for investors 1.
Opportunities
- AIM admission could improve the market profile and give access to natural resources investors, if the transaction completes 1.
- If the Ontario exploration programme yields favourable results, the company could build long-term value for shareholders 1.
- A gold project in a stable jurisdiction could attract investors seeking defensive assets amid uncertain macroeconomic conditions 1.
Threats
- Funding for the Eagle Lake transaction is not assured, and vendors may not accept shares as consideration, which could block the acquisition 1.
- Exploration risks, including geological uncertainty and permitting delays, could adversely affect the company's prospects 1.
- Exchange rate movements between sterling and the Canadian dollar could change reported results and budget planning 1.
Risks
- Single-asset dependencyhigh
After the Eagle Lake acquisition the company will depend on one exploration project, and permitting problems or cost increases could have a material impact 1.
- Transaction financinghigh
The company may be unable to secure the funding needed to complete the Eagle Lake acquisition or to advance the project afterwards 1.
- Exploration riskmedium
Geological results are uncertain and exploration may not produce commercially viable discoveries 1.
- Currency riskmedium
Exposure to the Canadian dollar after the acquisition could cause significant fluctuations in results reported in pounds sterling 1.
- Acquisition riskmedium
Due diligence may identify issues that delay or abort transactions, as happened with the Abyssinian Metals reverse takeover 1.
Investment thesis
What would need to be true (bull case)
- If the Eagle Lake transaction completes and exploration confirms the project's potential, the company could build a solid position in a gold asset in a stable jurisdiction 1.
- AIM admission could widen the investor base and improve access to capital for the next stages of development 1.
- Low administrative costs and board discipline could allow the company to preserve capital until a successful acquisition 1.
What would break the thesis
- If funding is not secured, the company could be left without a transaction and may have to reconfigure its strategy again 1.
- Dependence on a single exploration project could expose shareholders to major losses if results are unfavourable 1.
- The company has no operating revenue, and losses could continue until a commercially viable discovery, if any, is made 1.
What to watch
- Completion of the Eagle Lake acquisition and the associated fundraise2026
- Start of the structured exploration programme at the Eagle Lake project2026
- Approval of the AIM admission and the governance changes that accompany itnext 10-K
- Trend in the loss before taxation and administrative costs versus fiscal 2025next 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Medcaw Investments Plc was incorporated in England and Wales and its principal activity is identifying and acquiring early-stage natural resource assets capable of generating long-term shareholder value 1. The company has no current operations that impact the community or environment, according to the annual report 1. Its strategy changed from life sciences to natural resources 1.
The loss before taxation fell from £432,360 in fiscal 2024 to £144,478 in fiscal 2025 1. The directors waived accrued prior-year director fees of £182,454, which were written off in full 1. The only employees are the directors, who are all considered key management personnel 1.
The primary strategic objective is completing a Qualifying Transaction in line with the investing policy 1. The board focuses on cost discipline, capital preservation and sufficient liquidity to meet obligations 1. If the Eagle Lake transaction completes, the company could become dependent on a single exploration asset 1.
Segments
Eagle Lake Gold Project
In December 2025 the board entered binding heads of terms to acquire 90% of the Eagle Lake Gold Project in Ontario, Canada 1. The project forms the basis of the proposed admission to AIM 1. The company intends to start a structured exploration programme in 2026, subject to completion and the fundraise 1.
Acquisitions in progress
The company evaluated several opportunities, including a proposed reverse takeover of Abyssinian Metals Limited, which the board abandoned due to a material dispute with Ethiopia 1. The shares resumed trading on 2 April 2025 1. The board continues to seek suitable acquisition and investment opportunities 1.
Market context
The company operates in the natural resources investment sector, where developing exploration projects depends on access to capital and market conditions 1. The report states that issuing ordinary shares is the primary intended route for funding acquisitions 1. Management describes gold as continuing to show defensive qualities amid macroeconomic uncertainty 1.
Ontario is described as a stable, mining-friendly jurisdiction with strong infrastructure and regulatory clarity 1. For the company, a move to AIM could provide access to a broader natural resources investor base 1.
Trends
- Interest in gold as a defensive assettailwind
The board sees gold as retaining defensive qualities in an uncertain macroeconomic environment, which supports its focus on a gold project 1.
- Jurisdictional stabilitytailwind
Ontario is described as stable with good infrastructure and clear regulation, which could reduce country risk for the proposed project 1.
- Access to capital for explorationheadwind
The company notes that capital markets may limit its ability to raise funds on favourable terms, and debt could impose operating restrictions 1.
- Currency exposure after acquisitionmixed
After completing the Eagle Lake acquisition the group will be exposed to the Canadian dollar, while its reporting currency is pounds sterling, which could cause fluctuations in reported results 1.
Competitive position
The annual report does not explicitly name direct competitors. Medcaw operates as an early-stage natural resources investing vehicle, and competition for acquisitions is described as a market condition rather than a list of rivals 1.
The company notes that suitable acquisition targets may not always be readily available and that due diligence can extend timelines or lead to acquisitions being abandoned 1.
- Abyssinian Metals Limited
Target of a reverse takeover abandoned in 2025 due to a dispute with Ethiopia; a rejected transaction rather than a direct rival 1.
- Other AIM-listed natural resources investors
The company hopes AIM admission will give access to a wider investor base, but the report names no individual competitors 1.
- Sellers of gold assets in Ontario
Acquisition of the Eagle Lake project depends on negotiation with the vendor, and the heads of terms are not yet completed 1.
- Other resource acquisition vehicles
The report does not name competing companies; competition is described only in general terms as availability of targets 1.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202518 Mar 2026
Sources
- [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / MEDCAW INVESTMENTS PLC · 31 Dec 2025
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.